Royal Care Hospital dedicates MRgFUS Technology

His Excellency, Mr. Naor Gilon, Ambassador of Israel to India, inaugurated and dedicated India’s first MRgFUS Technology to the nation in the presence of Dr. K. Madeswaran, Chairman and Managing Director, Royal Care Super Speciality Hospital, and other dignitaries in the city. 

Royal Care Super Speciality Hospital, Coimbatore has set up India’s First MRgFUS (Magnetic Resonance Guided Focused Ultrasound Surgery) – a new technology for the treatment of Essential Tremors and Tremor Dominant Parkinson’s disease.  MRgFUS is a technology that has the potential to change the way movement disorders are being treated. 

Standard Control Organization

Tremors have long been treated with various medications without significant benefit. For the treatment of essential tremors and tremor-dominant Parkinson’s disease MRgFUS is approved by the Central Drugs Standard Control Organization (CDSCO) which is a part of the Ministry of Health and Family Welfare of India. MRgFUS has also been approved by the US Food and Drug Administration (USFDA). 

According to Dr. K. Madeswaran, Chairman and Managing Director, of Royal Care Super Speciality Hospital, “the Royal Care Super Speciality Hospital is equipped with advanced medical equipment and technologies and has often been the first in introducing the latest innovations in the medical field to the country.  The newest and the most advanced of them is the Magnetic Resonance Guided Focused Ultrasound for the treatment of essential tremors and tremor-dominant Parkinson's disease. ''